Latest News & Updates

Breaking News

  • 4 hours ago

  • Pharma Now Editorial Team

Novartis's $23B US buildout reshapes domestic API supply calculus
Breaking News
Kapiglucagon IND program tests 505(b)(2) prodrug strategy

Pharma Now Editorial Team

Other trending news you may like to read

Novartis's $23B US buildout reshapes domestic API supply calculus

Novartis's seventh US site, a dedicated API facility in Morrisville, NC, is part of a $23B domestic expansion targeting solid dosage and RNA therapeutics supply.

Pharma Now Editorial Team

Pharma Now

Kapiglucagon IND program tests 505(b)(2) prodrug strategy

ImmuPharma initiates IND-enabling activities for Kapiglucagon, engaging tranScrip to prepare a pre-IND FDA meeting and evaluate a 505(b)(2) pathway for the glucagon prodrug.

Pharma Now Editorial Team

Pharma Now

Kuehne and Nagel’s Hyderabad Hub Sets New Standard for Indian Cold Chain Logistics

Kuehne+Nagel's new Hyderabad facility raises GDP-compliant cold chain standards for Indian API and vaccine exporters serving EU and US markets.

Pharma Now Editorial Team

Pharma Now

Pharco's $28M expansion tests GMP ambition in African markets

Pharco Pharmaceuticals commits $28M to build an integrated African manufacturing network, raising GMP compliance and vendor qualification questions for regional supply chains.

Pharma Now Editorial Team

Pharma Now